CM
Connor McDermott
OtherActiveAssociate at Northpond Ventures
34
Investments
0
Exits
—
AUM
0.0%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Connor McDermott.
Investment Thesis & Strategy
Connor McDermott, as an associate at Northpond Ventures, invests in various stages of biotech companies, focusing on those with the potential for significant impact on human health and well-being.
Investment Activity
Deals per year over the last 3 years
5
20192
20201
2021Portfolio Companies
Selected investments from their portfolio of 34 companies
T
Teckro
Healthcare · Series B, 0
D
DNAnexus
Biotech · Series C+, 0
9
908 Devices
Biotech · Series C+, 0
H
Hawthorne Effect
Healthcare · Seed, 0
F
Farcast
Biotech · Seed, 2021
A
Artisan Bio
Biotech · Seed, 2020
V
Vizgen
Other · , 2020
V
Vigil Neuroscience
Biotech · Series A, 2019
G
General Automation Lab Technologies
Biotech · Seed, 2019
A
Aro Biotherapeutics
Biotech · Series B, 2019
S
Sherlock Biosciences
Biotech · Series B, 2019
E
Encodia
Biotech · Series B, 2019
Frequently Asked Questions
Connor McDermott focuses on Seed stage investments.